Aortic Abdominal Aneurysm Pilot Screening Programme

Analysis of Aortic Abdominal Aneurysm Prevalence in a Population Pilot Screening Program Based on Primary Care Duplex Ultrasound Evaluation

Populational abdominal aortic aneurysm (AAA) pilot screening programme performed by duplex ultrasonography in population born in 1952 in health areas depending from Hospital de la Santa Creu i Sant Pau in Barcelona. Descriptive data analysis and cost-effectiveness study will be performed.

Study Overview

Status

Completed

Detailed Description

Populational abdominal aortic aneurysm (AAA) pilot screening programme performed by duplex ultrasonography in population born in 1952 in areas depending from Hospital de la Santa Creu i Sant Pau in Barcelona. Ultrasonography evaluations will be performed in primary health centers by previously trained doctors according to study protocol and AAA management will be according to United Kingdom's National Health Service screening model. A descriptive analysis will be performed to estimate local population prevalence of AAA in both men and women in order to create the basis for a future state AAA screening programme. A cost-effectiveness analysis will be performed in order to assess optimal screening strategies in our population.

Study Type

Observational

Enrollment (Actual)

2194

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 65 years (Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All men and a random sample of women born in 1952 in Barcelona in the area that depends from Hospital de la Santa Creu i Sant Pau.

Description

Inclusion Criteria:

  • All men in our area's population census and an aleatory sample of women born in 1952 living in Hospital de la Santa Creu i Sant Pau area.

Exclusion Criteria:

  • Previously detected or operated AAA
  • Fragile patients not eligible for AAA repair if needed
  • Dead people when contacted
  • Eligible people refusing to participate
  • Eligible people failed to be contacted twice by our department

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Men
Men born in 1952 in Barcelona in health areas depending from Hospital de la Santa Creu i Sant Pau.
Abdominal ultrasonography performed by both primary care doctors or vascular surgeons in Hospital de la Santa Creu i Sant Pau area
Women
Aleatory sample of women born in 1952 in Barcelona in health areas depending from Hospital de la Santa Creu i Sant Pau.
Abdominal ultrasonography performed by both primary care doctors or vascular surgeons in Hospital de la Santa Creu i Sant Pau area

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Abdominal aortic measurement
Time Frame: Days (only one day measurement is performed)
Ultrasound infrarrenal aortic diameter measurement in mm
Days (only one day measurement is performed)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Smoking habits
Time Frame: 1 day
Defined by current smoker, former smoker (more than one year without smoking) or non smoker
1 day
Surgical intervention if needed
Time Frame: 1 day
Registry of kind of intervention and date of intervention
1 day
Family AAA history
Time Frame: 1 day
First or second degree relatives with AAA, or no family AAA history
1 day
Personal Cardiovascular Risk Factors
Time Frame: 1 day
Coronary disease, neurovascular disease, peripheral arterial disease or diabetes mellitus
1 day
Dislipidaemia
Time Frame: 1 day
Altered lipid parameters in blood analysis
1 day
Arterial Hypertension
Time Frame: 1 day
Arterial hypertension under medical treatment
1 day
Height
Time Frame: 1 day
measures in cm
1 day
Weight
Time Frame: 1 day
measures in kg
1 day
Abdominal perimeter
Time Frame: 1 day
measures in cm
1 day
Goldberg questionnaire
Time Frame: 1 day
Complete goldberg anxiety and depression questionnaire. It consists of 12 questions and 5 posible answers for each question, and each answer is rated with 1 to 5 points. Total score above 9 indicates risk of depression.
1 day
EuroQOL 5 score
Time Frame: 1 day
EuroQOL 5 quality of life evaluation questionnaire. It consistis of 5 questions with 3 posible answers for each question, and a visual analogical scale for self health perception. Each combination of answers indicates a pattern of health status that can be rated.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

December 31, 2017

Study Completion (Actual)

June 1, 2018

Study Registration Dates

First Submitted

June 14, 2018

First Submitted That Met QC Criteria

August 3, 2018

First Posted (Actual)

August 6, 2018

Study Record Updates

Last Update Posted (Actual)

August 6, 2018

Last Update Submitted That Met QC Criteria

August 3, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • IIBSP-AAA-2017-42

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aortic Aneurysm, Abdominal

Clinical Trials on ABDOMINAL DUPLEX ULTRASONOGRAPHY

3
Subscribe